Launching in 2026, IJTLD Chronic Respiratory Disease (IJTLD CRD) is a new open access journal (fully compliant with Plan S). The Journal will feature the latest research on CRDs in low- and middle-income countries (LMICs), which is a badly neglected area, with an estimated 4 million deaths each year, and 28–90 million people living with post-TB lung disease (PTLD).
Our aim is to improve access to knowledge and influence care, policy and practise for better health, and each issue of IJTLD CRD will include a mix of articles on chronic disease, including:
PTLD – Asthma – COPD – Impact of air pollution – Lung damage in smokers – Interstitial lung disease – Bronchiectasis – Long COVID – Sleep apnea – Occupational lung disease
We encourage authors working on chronic respiratory disease to submit their latest research on all aspects of the management and care of patients. We will consider Editorials, Original Research (including methodology papers, qualitative research and impactful operational research), Reviews, Viewpoints, Case Reports and Letters.
We are particularly keen to promote research on early diagnosis and treatments – including the latest therapeutic advances that have relevance across a wide range of respiratory conditions. Overall, we aim to highlight the importance of these conditions to influence policymakers and improve clinical care in LMICs.
For all queries please e-mail the Editorial team at journal@theunion.org
While preparing their article, authors should refer to the Instructions for Authors to check that they have complied with our requirements – see links below.
Once complete, authors should submit their manuscripts at http://mc.manuscriptcentral.com/ijtld
Sponsorship
Supplements and article series are a highly-effective way of highlighting a specific topic to researchers, clinicians and decision makers in respiratory health.
Being an Open Access journal, IJTLD CRD has no barriers to access and can reach readers in health centres, medical, university and pharmaceutical institutes, along with civil society, patients and carers.
All content will be freely available and acknowledge the sponsors support and readers will receive emails to highlight sponsored content.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD, IJTLD OPEN and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
Conflation of prediction and causality in the TB literature
A forthcoming IJTLD OPEN article addresses the frequent conflation of prediction and causal inference in observational TB studies, and outlines practical recommendations to enhance research precision and transparency.
The rationale for cancer to be made a notifiable disease in India
In this Short Communication (to be published in the Q2 issue of PHA), the authors explain why the Ministry of Health in India should make cancer a notifiable disease.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.